HHS Logo U.S. Department of Health & Human Services Divider arrowNIH logo National Institutes of Health Alt desc
Skip Over Navigation Links
A depressed person sitting in chair

A depressed person sitting in chair

NCATS scientists helped identify a chemical byproduct created as the body breaks down ketamine — a finding that has potential for treating depression.

Students look at computer screens

Researcher Embraces Technology to Improve Hearing Device

A CTSA Program-supported scientist is moving a promising translational research project into commercial space.

On the left is a normal lung and on the right is a lung affected by lymphangioleiomyomatosis.

On the left is a normal lung and on the right is a lung affected by lymphangioleiomyomatosis.

NCATS-supported research collaboration leads to FDA approval of drug to treat lymphangioleiomyomatosis.

NCATS e-newsletter displayed on a tablet

NCATS April E-Newsletter

Read about how the CTSA Program enabled a researcher to develop a device to improve cochlear implants, the expansion of a medicinal ingredients database system and more.

Recursion Pharmaceuticals Employees

Small Business Award Helps Launch Drug Discovery Platform

NCATS funding enabled a scientist and entrepreneur to catalyze innovation in translational science.

Ketamine Metabolite Fights Depression

NCATS scientists helped identify a chemical byproduct created as the body breaks down ketamine — a finding that has potential for treating depression.

A depressed person sitting in chair

Researcher Embraces Technology to Improve Hearing Device

A CTSA Program-supported scientist is moving a promising translational research project into commercial space.

Students look at computer screens

April E-Newsletter Now Available

Read about how the CTSA Program enabled a researcher to develop a device to improve cochlear implants, the expansion of a medicinal ingredients database system and more.

NCATS e-newsletter displayed on a tablet

First Treatment for Rare Lung Disease Approved

NCATS-supported research collaboration leads to FDA approval of drug to treat lymphangioleiomyomatosis.

On the left is a normal lung and on the right is a lung affected by lymphangioleiomyomatosis.

Small Business Award Helps Launch Drug Discovery Platform

NCATS funding enabled a scientist and entrepreneur to catalyze innovation in translational science.

Recursion Pharmaceuticals Employees

More Center News

BEST Resource coverBEST Resource Glossary
This online glossary clarifies terms used in translational science and medical product development.

Assay Guidance Manual cover artAssay Guidance Manual
Use this NCATS-supported tool to develop tests for high-throughput screening projects.

  • Facebook icon
  • Twitter icon
  • YouTube icon

Director's Corner

Watch a CTSA Program Video

NCATS CTSA Program Interview

Petra Kaufmann, M.D., M.Sc., director of the NCATS Office of Rare Diseases Research and Division of Clinical Innovation, discusses how CTSA Program support is speeding the translation of research discoveries into health benefits. View the video.

Work with Us

Learn more about all the ways that potential grantees, partners and collaborators can access NCATS support to advance translational science.

  • NCATS Programs & Initiatives
    NCATS encourages partnerships that cross many scientific disciplines and research sectors in pursuit of translational success.
  • Small Business Opportunities
    NCATS’ small business programs help entrepreneurs develop and commercialize new translational technologies.
  • Expertise & Resources
    NCATS staff are experts in translation, and the Center’s resources support pre-clinical and clinical activities.
  • Licensing Opportunities
    NCATS makes it easy for industry and academia to interact and partner with Center laboratories and scientists.